• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2020-2022 年优化东非共同体药品监管协调倡议：未来路线图。

Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future.

机构信息

Drug and Food Control Authority, Juba, South Sudan.

Directorate of Pharmacy, Medicines, and Laboratories, Bujumbura, Burundi.

出版信息

PLoS Med. 2020 Aug 12;17(8):e1003129. doi: 10.1371/journal.pmed.1003129. eCollection 2020 Aug.

DOI:10.1371/journal.pmed.1003129
PMID:32785229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7423061/
Abstract

Margareth Ndomondo-Sigonda outlines future challenges for the East African Medicines Regulatory Harmonization initiative.

摘要

玛格丽特·恩多蒙多-西冈达概述了东非药品监管协调倡议面临的未来挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2644/7423061/bb52a7eac1bb/pmed.1003129.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2644/7423061/dd748634e00c/pmed.1003129.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2644/7423061/bb52a7eac1bb/pmed.1003129.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2644/7423061/dd748634e00c/pmed.1003129.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2644/7423061/bb52a7eac1bb/pmed.1003129.g002.jpg

相似文献

1
Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future.2020-2022 年优化东非共同体药品监管协调倡议：未来路线图。
PLoS Med. 2020 Aug 12;17(8):e1003129. doi: 10.1371/journal.pmed.1003129. eCollection 2020 Aug.
2
Coming together to improve access to medicines: The genesis of the East African Community's Medicines Regulatory Harmonization initiative.汇聚力量，改善药品可及性：东非共同体药品监管协调倡议的缘起。
PLoS Med. 2020 Aug 12;17(8):e1003133. doi: 10.1371/journal.pmed.1003133. eCollection 2020 Aug.
3
A new approach to an old problem: Overview of the East African Community's Medicines Regulatory Harmonization initiative.解决老问题的新方法：东非共同体药品监管协调倡议概述
PLoS Med. 2020 Aug 12;17(8):e1003099. doi: 10.1371/journal.pmed.1003099. eCollection 2020 Aug.
4
Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative.提高东非获得高质量药物的机会：对东非共同体药品监管协调倡议的独立看法。
PLoS Med. 2020 Aug 12;17(8):e1003092. doi: 10.1371/journal.pmed.1003092. eCollection 2020 Aug.
5
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.东非共同体药品监管协调倡议八年：实施、进展和经验教训。
PLoS Med. 2020 Aug 12;17(8):e1003134. doi: 10.1371/journal.pmed.1003134. eCollection 2020 Aug.
6
Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative.对当前东非共同体药品监管协调联合审查程序的建议改进以及该倡议的新审查模式提案。
Pharmaceut Med. 2025 Mar;39(2):125-141. doi: 10.1007/s40290-025-00554-1. Epub 2025 Mar 4.
7
Requirements for generic anti-epileptic medicines: a regulatory perspective.通用抗癫痫药物的要求：监管视角
J Neurol. 2009 Dec;256(12):1966-71. doi: 10.1007/s00415-009-5231-2. Epub 2009 Jul 15.
8
Industrial perceptions of medicines regulatory harmonization in the East African Community.东非共同体中对药品监管协调的产业看法。
PLoS One. 2019 Jun 19;14(6):e0218617. doi: 10.1371/journal.pone.0218617. eCollection 2019.
9
African Medicines Agency to be established.非洲药品管理局即将成立。
Lancet. 2021 Oct 23;398(10310):1475. doi: 10.1016/S0140-6736(21)02310-2.
10
The African medicines regulatory harmonization initiative: rationale and benefits.非洲药品监管协调倡议：原理与效益。
Clin Pharmacol Ther. 2011 Feb;89(2):176-8. doi: 10.1038/clpt.2010.299.

引用本文的文献

1
Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative.对当前东非共同体药品监管协调联合审查程序的建议改进以及该倡议的新审查模式提案。
Pharmaceut Med. 2025 Mar;39(2):125-141. doi: 10.1007/s40290-025-00554-1. Epub 2025 Mar 4.
2
A 20-year evidence-based experience of the evolving medicine regulation in Zanzibar.桑给巴尔20年基于证据的医学监管发展经验。
J Pharm Policy Pract. 2024 Nov 7;17(1):2421273. doi: 10.1080/20523211.2024.2421273. eCollection 2024.
3
Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978-2020.

本文引用的文献

1
Industrial perceptions of medicines regulatory harmonization in the East African Community.东非共同体中对药品监管协调的产业看法。
PLoS One. 2019 Jun 19;14(6):e0218617. doi: 10.1371/journal.pone.0218617. eCollection 2019.
2
Emerging Technologies for Molecular Diagnosis of Sepsis.脓毒症分子诊断的新兴技术。
Clin Microbiol Rev. 2018 Feb 28;31(2). doi: 10.1128/CMR.00089-17. Print 2018 Apr.
3
The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa.
加强坦桑尼亚医疗产品监管：1978 - 2020年监管能力发展评估
PLOS Glob Public Health. 2024 Oct 16;4(10):e0003241. doi: 10.1371/journal.pgph.0003241. eCollection 2024.
4
Good manufacturing practice inspections conducted by Tanzania medicines and medical devices authority: a comparative study of two fiscal years from 2018 to 2020.坦桑尼亚药品和医疗器械管理局进行的药品生产质量管理规范检查：2018年至2020年两个财政年度的比较研究
J Pharm Policy Pract. 2024 Sep 16;17(1):2399722. doi: 10.1080/20523211.2024.2399722. eCollection 2024.
5
Identifying and costing common gaps in Central and West Africa pharmaceutical regulation.识别并计算出中非和西非药品监管中常见的差距及成本。
Front Med (Lausanne). 2024 Apr 5;11:1362253. doi: 10.3389/fmed.2024.1362253. eCollection 2024.
6
The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.批准建立非洲药品管理局条约的过程：国家监管机构的观点。
Health Policy Plan. 2024 May 15;39(5):447-456. doi: 10.1093/heapol/czae017.
7
Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.非洲药品监管协调倡议中的最佳实践：监管机构与药品制造商的观点
PLOS Glob Public Health. 2023 Apr 26;3(4):e0001651. doi: 10.1371/journal.pgph.0001651. eCollection 2023.
8
Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.制定南部非洲药物警戒指南评估清单：文献综述
Ther Adv Drug Saf. 2023 Jan 24;14:20420986221143272. doi: 10.1177/20420986221143272. eCollection 2023.
9
The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda.年轻的国家药品监管当局确保药品质量的能力：卢旺达的情况
J Pharm Policy Pract. 2022 Nov 24;15(1):90. doi: 10.1186/s40545-022-00492-2.
10
Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.制药公司对东非共同体联合评估程序的有效性和效率评估：改进机会
Front Pharmacol. 2022 Nov 3;13:1031289. doi: 10.3389/fphar.2022.1031289. eCollection 2022.
到2030年让所有非洲人实现更长寿、更健康生活的路径：《柳叶刀》撒哈拉以南非洲地区健康未来委员会
Lancet. 2017 Dec 23;390(10114):2803-2859. doi: 10.1016/S0140-6736(17)31509-X. Epub 2017 Sep 13.
4
A novel rapid test for detecting antibody responses to Loa loa infections.一种用于检测对罗阿丝虫感染的抗体反应的新型快速检测方法。
PLoS Negl Trop Dis. 2017 Jul 27;11(7):e0005741. doi: 10.1371/journal.pntd.0005741. eCollection 2017 Jul.
5
Essential medicines for universal health coverage.全民健康覆盖的基本药物。
Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8.
6
Combating poor-quality anti-malarial medicines: a call to action.打击劣质抗疟药物：行动呼吁。
Malar J. 2016 Jun 1;15:302. doi: 10.1186/s12936-016-1357-8.
7
Artesunate- and amodiaquine-associated extrapyramidal reactions: information gained from an African-based risk management plan.
Drug Saf. 2013 Jan;36(1):71-2. doi: 10.1007/s40264-012-0010-x.
8
Artesunate- and amodiaquine-associated extrapyramidal reactions: a series of 49 cases in VigiBase™.青蒿琥酯和阿莫地喹相关的锥体外系反应：VigiBase™中的 49 例系列病例。
Drug Saf. 2012 Aug 1;35(8):667-75. doi: 10.1007/BF03261963.